- TWD19.08bn
- TWD16.52bn
- TWD1.01bn
Annual balance sheet for EirGenix, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 937 | 8,290 | 7,127 | 5,553 | 4,598 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 230 | 259 | 298 | 588 | 561 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,494 | 9,070 | 8,288 | 6,916 | 5,952 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,177 | 2,185 | 3,032 | 3,681 | 4,360 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,835 | 11,441 | 11,847 | 11,163 | 10,876 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 642 | 703 | 731 | 707 | 947 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,930 | 1,012 | 1,164 | 1,145 | 1,618 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,906 | 10,429 | 10,683 | 10,017 | 9,258 |
Total Liabilities & Shareholders' Equity | 3,835 | 11,441 | 11,847 | 11,163 | 10,876 |
Total Common Shares Outstanding |